Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Imatinib can cause hair loss due to lichen planopilaris.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

The higher dose supplement was more effective in treating female hair loss.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.

Tofacitinib effectively treats Alopecia Areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Zinc supplements and weaning cured a breast-fed baby's zinc deficiency caused by a gene mutation.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Strontium ranelate is no longer available for treatment.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.